The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 ...

The Catalyst ® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome WESTBROOK, Maine, June 5, 2025 /PRNewswire/ -- ...

WESTBROOK, Maine, Jan. 13, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One(TM) Chemistry Analyzer.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) has announced the commercial launch of its Catalyst SDMA Test to all North American customers, scheduled on Jan 16, 2018. With this, IDEXX’s point-of-care ...

Pancreatitis is a common disease among cats and dogs, and while treatable, it can prove fatal if not caught early. Diagnosing pancreatitis can be difficult due to its nonspecific symptoms and subtle ...

The Catalyst Cortisol Test will be available in the U.S. and Canada at the end of July 2025, with a global rollout to the installed base of more than 75,000 Catalyst chemistry analyzers expected to ...

WESTBROOK, Maine, Jan.13, 2014 /PRNewswire/ --IDEXX Laboratories, Inc. (NASDAQ: IDXX) announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One' Chemistry ...

The Catalyst® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome "The Catalyst Cortisol Test is an accurate and ...